SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-069110
Filing Date
2024-06-06
Accepted
2024-06-06 16:25:21
Documents
13
Period of Report
2024-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416552d1_8k.htm   iXBRL 8-K 30889
  Complete submission text file 0001104659-24-069110.txt   206977

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aplt-20240606.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20240606_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20240606_pre.xml EX-101.PRE 22381
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2416552d1_8k_htm.xml XML 3770
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 241025390
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)